top of page

Poster 53

Deucravacitinib, an Oral, Selective, Allosteric Tyrosine Kinase 2 Inhibitor, in Moderate-to-Severe Plaque Psoriasis: 2-Year Efficacy by Prior Biologic Treatment in the Phase 3 POETYK PSO Program


Authors: Richard B. Warren, April W. Armstrong, Shinichi Imafuku, Carle Paul, Leon Kircik, Subhashis Banerjee, Elizabeth Colston, Thomas Scharnitz, Tao Wang, Bruce Strober


POSTER 53

21 views0 comments

Comments


QUESTIONS, COMMENTS, & SURVEY

Please Rate This PosterPoorFairGoodVery goodExcellentPlease Rate This Poster
Thank you for submitting your feedback!

Search by Poster Number

bottom of page